Parvez M. Lokhandwala, MD, PhD

Inova providers are Inova's premier primary care and specialty physicians and providers, offering top-notch medical expertise, full access to Inova facilities, and the convenience of integrated electronic medical records. 

Parvez Lokhandwala, MD, PhD
Parvez Lokhandwala, MD, PhD

Parvez M. Lokhandwala, MD, PhD

Inova providers are Inova's premier primary care and specialty physicians and providers, offering top-notch medical expertise, full access to Inova facilities, and the convenience of integrated electronic medical records. 

Specialty
Pathology-Clinical, Pathology-Molecular Genetics, Blood Banking/Transfusion Medicine
Years of Experience
24
Gender
Male
Languages
English
Request Profile Update
Locations
Inova Pathology Institute

2832 Juniper St
Fairfax, VA 22301-4402

Get Directions Details
Phone
703-645-6116
Fax
703-776-3100

About Parvez M. Lokhandwala, MD, PhD

Dr. Parvez Lokhandwala is a specialty care physician board certified in clinical pathology, molecular genetic pathology and blood banking and transfusion medicine. He joined Inova in 2025 and has been practicing since 2012.

Dr. Lokhandwala has a primary role at Inova Laboratories, where he focuses on systems and quality-improvement projects that enhance operational efficiency and patient safety.

Prior to joining Inova, Dr. Lokhandwala directed the apheresis service at Johns Hopkins Hospital and was the Medical Director of the American Red Cross Biomedical Services in the MD and DC regions. He held several laboratory leadership roles in the University of Maryland Medical System including CLIA Medical Director of the NGS-enabled molecular diagnostic laboratory, CLIA Medical Director of the clinical laboratory at UM Rehab and Orthopaedic Institute, Medical Director of the blood and tissue banks, and Chair of the System Blood Bank and Transfusion Medicine Committee.

Publications

Lokhandwala PM, O'Neal A, Patel EU, Brunker PAR, Gehrie EA, Zheng G, Kickler TS, Ness PM, Tobian AAR. Hemostatic profile and safety of pooled cryoprecipitate up to 120 hours after thawing. Transfusion. 2018 May;58(5):1126-1131. doi: 10.1111/trf.14550. Epub 2018 Feb 25.PMID:29479708

McGonigle AM, Patel EU, Waters KM, Moliterno AR, Thoman SK, Vozniak SO, Ness PM, King KE, Tobian AAR, Lokhandwala PM. Solvent detergent treated pooled plasma and reduction of allergic transfusion reactions. Transfusion. 2020 Jan;60(1):54-61. doi: 10.1111/trf.15600. Epub 2019 Dec 16.PMID:31840276

Lokhandwala PM, Young PP, White J, Brown BL. Cryoprecipitated anti-hemophiliac factor manufactured from plasma frozen within 24h after phlebotomy meets AABB quality standards. Transfusion. 2022 Sep;62(9):1731-1735. doi: 10.1111/trf.17032. Epub 2022 Jul 27.PMID:35894539

Buban KR, Lawrence CE, Zhu XJ, Tobian AAR, Gehrie EA, Vozniak S, Shrestha R, Lokhandwala PM, Bloch EM. Algorithm-based selection of automated red blood cell exchange procedure goals reduces blood utilization in chronically transfused adults with sickle cell disease. J Clin Apher. 2022 Oct;37(5):468-475. doi: 10.1002/jca.22004. Epub 2022 Aug 22.PMID:36053868 (*contributed equally).

Medical School
Medical College of Baroda
Residencies
Penn State Milton S. Hershey Medical Center
Training Specialty: Pathology-Anatomic/Pathology-Clinical
7/01/2012 - 6/30/2015
Fellowships
Johns Hopkins University School of Medicine
Training Specialty: Molecular Genetics
7/01/2015 - 6/30/2016
Johns Hopkins University School of Medicine
Training Specialty: Transfusion Medicine
7/01/2016 - 6/30/2017
Hospital Affiliations
Inova Alexandria Hospital
Inova Fairfax Hospital
Inova Fair Oaks Hospital
Inova Loudoun Hospital
Inova Mount Vernon Hospital

Patient Reviews

About Patient Comments

The Patient Rating score is an average of all responses to physician related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.